Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
PT-141 (bremelanotide, brand name Vyleesi) is approved for hypoactive sexual desire disorder in premenopausal women
For low doses (0.25-0.5mg at 2.5 mg/mL), a 0.3 mL (30 unit) syringe provides larger graduation marks that are easier to read than a 1 mL (100 unit) syringe
[ref] A study in rats found that the therapeutic effect of BPC-157 was achieved through consolidating the stimulating and inhibiting effects of the NO system
Getting It Right First Time
Purchased 10 viles and it came within 3 days
US$ 21.44
US$ 20.73
US$ 27.72
US$ 20.27
US$ 20.38
US$ 29.25
